Natural Compound

Green Coffee Extract

Coffea arabica / Coffea canephora (green coffee bean extract, chlorogenic acid)

Evidence TierCWADA NOT PROHIBITED

tuneTypical Dose

120-300 mg CGA daily

watchEffect Window

4-8 weeks for early signal. 12-week BP endpoint confirmation.

check_circleCompliance

WADA NOT PROHIBITED

Overview

Clinical Summary

Green coffee extract is derived from unroasted coffee beans and provides chlorogenic acids. It has modest evidence for blood-pressure support and only small weight-loss effects.

Some trials report modest weight loss and small improvements in fasting glucose, though study quality varies and effects are often small. Blood pressure reductions have been observed in certain groups. Minority evidence explores antioxidant and liver fat biomarkers, with mixed findings. Caffeine content varies and can influence both perceived benefits and side effects such as insomnia or anxiety.

Chlorogenic acid may inhibit glucose-6-phosphatase and carbohydrate absorption. Ferulic acid pathways may support nitric-oxide-related vascular signaling.

Outcomes

What This Is Expected To Influence

Primary Outcomes

  • Lower systolic and diastolic blood pressure in adults with mild hypertension.

Secondary Outcomes

  • Modest 1-2 kg weight reduction in some overweight adults.

Safety

Contraindications and Interactions

Contraindications

  • Pregnancy
  • Lactation
  • High-risk comorbid disease
  • Caffeine sensitivity

Side effects

  • Insomnia
  • Anxiety
  • Headache
  • GI upset
  • Palpitations

Interactions

  • Uncertain

Avoid if

  • Active malignancy
  • Unstable cardiovascular or psychiatric disease

Evidence

Study-level References

green-coffee-extract-SRC-WAT-2006Randomized controlled trial

Watanabe et al. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. 2006.

Population: Adults with mild hypertension

Dose protocol: 140 mg chlorogenic acid, before major meals, daily for 12 weeks

Key findings: Watanabe 2006 RCT reported lowering of systolic and diastolic blood pressure versus control.

Notes: Weight/BMI outcomes were not the primary endpoint and remain secondary/variable.

Paper content

This older randomized trial in adults with mild hypertension used a chlorogenic-acid-rich green coffee bean extract for 12 weeks and reported lower systolic and diastolic blood pressure versus control. It remains the most direct human trial behind green coffee's blood-pressure framing, but it does not support the stronger weight-loss marketing that became attached to the ingredient later.

green-coffee-extract-SRC-UMB-2023Umbrella review of interventional meta-analyses.
Sourceopen_in_new

Asbaghi O, et al. The effect of green coffee extract supplementation on obesity indices: critical umbrella review of interventional meta-analyses. 2023. doi:10.1186/s12916-023-02925-9. PMID:37341701.

Population: Adults represented across published interventional meta-analyses of green coffee extract for obesity indices.

Dose protocol: Mixed green coffee extract protocols across published interventional meta-analyses

Key findings: Umbrella review found small reductions in body weight, BMI, and waist circumference.

Notes: Useful for de-inflating the historical fat-loss marketing because the pooled effects are real but modest.

Paper content

This umbrella review summarized interventional meta-analyses of green coffee extract and found small but statistically significant reductions in body weight, BMI, and waist circumference. The signal is directionally positive, but the effect sizes are modest and still sit on top of a literature base with substantial product heterogeneity and older low-quality trials. It supports a narrow adjunct framing for body-weight management, not the aggressive fat-loss claims that drove the supplement's early marketing.

Guides

Setup

Help